Inventor · disambiguated record
Paul-Joseph Penaflor Aspuria
Also filed as: PENAFLOR-ASPURIA PAUL-JOSEPH
0 granted patents·4 pending applications·0 citations·filing 2021–2021
Files withSYNTHEKINE INC4
Top patents by PatentIndex Score
4 records- 0151US2023374454A1Human immune cells genomically modified to express orthogonal receptorsSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 0250US2023027899A1Cd122 with altered icd stat signalingSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 0349US2023076768A1IL2 Orthologs and Methods of UseSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 0448US2023159892A1Engineered immune cellsSYNTHEKINE INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul-Joseph Penaflor Aspuria files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →